Dr. Bedingfield’s clinical and academic career has focused on tuberculosis (TB) care. This depth of experience provides her with a strong TB knowledge base and an extensive professional network. In 2008, she began working as a Registered Nurse at the Calgary TB Clinic and maintains close ties with the clinic. She is currently working under Dr. Dick Menzies and Dr. Amrita Daftary as a post-doctoral fellow after having completed a PhD focused on TB (University of Calgary – 2022), a 1-year work term as a TB Project Manager with the National Collaborating Centre for Infectious Disease (2023-University of Manitoba), and a 7 year placement as the Calgary Site Coordinator for 3 clinical trials operating in Dr. Dick Menzies’ research group. For her doctoral dissertation, Dr. Bedingfield used qualitative methods to explore patient education for people born outside of Canada and their family members experiencing infectious TB. Under the supervision of Dr. Daftary and Dr. Menzies, her post-doctoral work will be focused on using mixed methods to explore quality of life during TB treatment for patients in South Africa, North America, and Vietnam.
Research Interests:
Tuberculosis; Qualitative and Mixed Methods; Patient Education and Counselling; Quality of Life
Themes | Global Health & Humanitarianism |
Status | Active |
Related Work | |
Updates |
N/A
|
You may also be interested in…
Recap — Springing into Action: Steps to Developing an Effective Action Plan
By this time of year, most people have abandoned any New Year’s resolutions they established back in January. On March 15, Prof. Harvey Skinner led the final instalment of the Wellness and Self-Care mini-series at …Read more about this Post
Recap – The Wellness Impact Lab Launches First Climate Cafe
Climate change can trigger complex feelings. On August 24, 2023, the Wellness Impact Lab launched its inaugural Climate Café. The core objectives of this event was to create a safe space for participants to voice …Read more about this Post
Advancing Social Science Research at UN Multi-stakeholder Hearings on Tuberculosis
Despite commendable advances in new Tuberculosis (TB) diagnostics and more safe and effective TB treatments, as depicted in the latest Global TB Report, 10.6 million people fell ill, and 1.6 million people died of TB …Read more about this Post